Mark Sorbero
YOU?
Author Swipe
View article: Associations Between State Policies Facilitating Telehealth and Buprenorphine Episode Initiation and Duration Early in the COVID Pandemic
Associations Between State Policies Facilitating Telehealth and Buprenorphine Episode Initiation and Duration Early in the COVID Pandemic Open
Importance State policies facilitating telehealth implemented early in COVID may support buprenorphine treatment of opioid use disorder. However, little empirical information is available about those policies’ effects. Objective Examine as…
View article: Hospital Strain During the COVID-19 Pandemic and Outcomes in Older Racial and Ethnic Minority Adults
Hospital Strain During the COVID-19 Pandemic and Outcomes in Older Racial and Ethnic Minority Adults Open
Importance Marginalized populations have been disproportionately affected by the COVID-19 pandemic. Critically ill patients belonging to racial and ethnic minority populations treated in hospitals operating under crisis or near-crisis cond…
View article: Autoregressive models for panel data causal inference with application to state-level opioid policies
Autoregressive models for panel data causal inference with application to state-level opioid policies Open
Motivated by the study of state opioid policies, we propose a novel approach that uses autoregressive models for causal effect estimation in settings with panel data and staggered treatment adoption. Specifically, we seek to estimate the i…
View article: Use of Inpatient Psychiatric Facilities by Medicare Beneficiaries with Dementia
Use of Inpatient Psychiatric Facilities by Medicare Beneficiaries with Dementia Open
Alzheimer's dementia, the most common type of dementia, afflicts more than 6 million Americans. More than 80 percent of people living with dementia (PLWD) live in the community, either with caregivers or alone. As cognitive impairment beco…
View article: Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009–2018
Differences in medicaid expansion effects on buprenorphine treatment utilization by county rurality and income: A pharmacy data claims analysis from 2009–2018 Open
Medicaid expansion was associated with a reduction in income-related buprenorphine disparities in urban counties, but not in rural counties. To achieve more equitable buprenorphine access, future policies should target low-income rural are…
View article: State Policy and the Breadth of Buprenorphine-Prescriber Networks in Medicaid Managed Care
State Policy and the Breadth of Buprenorphine-Prescriber Networks in Medicaid Managed Care Open
Provider networks in Medicaid Managed Care (MMC) play a crucial role in ensuring access to buprenorphine, a highly effective treatment for opioid use disorder. Using a difference-in-differences approach that compares network breadth across…
View article: Buprenorphine Treatment Episodes During the First Year of COVID: a Retrospective Examination of Treatment Initiation and Retention
Buprenorphine Treatment Episodes During the First Year of COVID: a Retrospective Examination of Treatment Initiation and Retention Open
View article: Buprenorphine treatment episode duration, dosage, and concurrent prescribing of benzodiazepines and opioid analgesics: The effects of Medicaid prior authorization policies
Buprenorphine treatment episode duration, dosage, and concurrent prescribing of benzodiazepines and opioid analgesics: The effects of Medicaid prior authorization policies Open
View article: Differences in buprenorphine treatment quality across physician provider specialties
Differences in buprenorphine treatment quality across physician provider specialties Open
View article: State Policies and Buprenorphine Prescribing by Nurse Practitioners and Physician Assistants
State Policies and Buprenorphine Prescribing by Nurse Practitioners and Physician Assistants Open
Nurse practitioner (NP) and physician assistant (PA) prescribing can increase access to buprenorphine treatment for opioid use disorder. In this cross-sectional study, we used deidentified claims from approximately 90% of U.S. retail pharm…
View article: Subsequent Buprenorphine Treatment Following Emergency Physician Buprenorphine Prescription Fills: A National Assessment 2019 to 2020
Subsequent Buprenorphine Treatment Following Emergency Physician Buprenorphine Prescription Fills: A National Assessment 2019 to 2020 Open
View article: Medicaid Payment and Fluoride Varnish Application During Pediatric Medical Visits
Medicaid Payment and Fluoride Varnish Application During Pediatric Medical Visits Open
All Medicaid programs pay for fluoride varnish applications during medical visits for infants and toddlers, but receipt of care varies considerably across states. Using 2006–2014 Medicaid data from 22 states, this study examined the associ…
View article: Sociodemographic Differences in Quality of Treatment to Medicaid Enrollees Receiving Buprenorphine
Sociodemographic Differences in Quality of Treatment to Medicaid Enrollees Receiving Buprenorphine Open
Background: Buprenorphine is a key medication to treat opioid use disorder, but little is known about how treatment quality varies across sociodemographic groups. Objective: We examined measures of treatment quality and explored variation …
View article: The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic
The effect of state policies on rates of high-risk prescribing of an initial opioid analgesic Open
View article: Change in Per Capita Opioid Prescriptions Filled at Retail Pharmacies, 2008–2009 to 2017–2018
Change in Per Capita Opioid Prescriptions Filled at Retail Pharmacies, 2008–2009 to 2017–2018 Open
LettersFebruary 2022Change in Per Capita Opioid Prescriptions Filled at Retail Pharmacies, 2008–2009 to 2017–2018Bradley D. Stein, MD, PhD, Erin A. Taylor, PhD, MSPH, Flora Sheng, MPH, Andrew W. Dick, PhD, Mary Vaiana, PhD, Mark Sorbero, M…
View article: Rapid Discontinuation of Chronic, High-Dose Opioid Treatment for Pain: Prevalence and Associated Factors
Rapid Discontinuation of Chronic, High-Dose Opioid Treatment for Pain: Prevalence and Associated Factors Open
View article: Infection Hospitalization Trends Among US Home Healthcare Patients, 2013–2018
Infection Hospitalization Trends Among US Home Healthcare Patients, 2013–2018 Open
Background: Infections are a frequent cause of hospital (re)admissions for older adults receiving home health care (HHC) in the United States. However, previous investigators have likely underestimated the prevalence of infections leading …
View article: Advanced cognitive impairment among older nursing home residents
Advanced cognitive impairment among older nursing home residents Open
View article: Infection trends in home health care, 2013–2018
Infection trends in home health care, 2013–2018 Open
An abstract is not available for this content. As you have access to this content, full HTML content is provided on this page. A PDF of this content is also available in through the ‘Save PDF’ action button.
View article: Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US
Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US Open
This study quantifies the total amount of buprenorphine care delivered by active prescribers and to what extent that varies across specialties.
View article: Trends in visits to substance use disorder treatment facilities in 2020
Trends in visits to substance use disorder treatment facilities in 2020 Open
View article: Does Integration of Palliative Care and Infection Management Reduce Hospital Transfers among Nursing Home Residents?
Does Integration of Palliative Care and Infection Management Reduce Hospital Transfers among Nursing Home Residents? Open
Background: An estimated 50% of nursing home (NH) residents experience hospital transfers in their last year of life, often due to infections. Hospital transfers due to infection are often of little clinical benefit to reside…
View article: Individual and Community Factors Associated with Naloxone Co-prescribing Among Long-term Opioid Patients: a Retrospective Analysis
Individual and Community Factors Associated with Naloxone Co-prescribing Among Long-term Opioid Patients: a Retrospective Analysis Open
View article: Patient, prescriber, and Community factors associated with filled naloxone prescriptions among patients receiving buprenorphine 2017-18
Patient, prescriber, and Community factors associated with filled naloxone prescriptions among patients receiving buprenorphine 2017-18 Open
View article: The Burden of Infection in Transfers from Nursing Homes to Hospitals
The Burden of Infection in Transfers from Nursing Homes to Hospitals Open
Background: The focus on infection prevention in nursing homes is growing, but little is known about the role infections play in transfers from nursing home to hospital. Our goals were (1) to identify rates of infection-related transfers t…
View article: Impact of a Medicaid policy on preventive oral health services for children with intellectual disabilities, developmental disabilities, or both
Impact of a Medicaid policy on preventive oral health services for children with intellectual disabilities, developmental disabilities, or both Open
View article: Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007–2017
Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007–2017 Open
Letters7 April 2020Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007–2017Ryan K. McBain, PhD, MPH, Andrew Dick, PhD, Mark Sorbero, MS, and Bradley D. Stein, MD, PhDRyan K. McBain, PhD, MPHRAND Corporati…
View article: Changes in US Nursing Home Infection Prevention and Control Programs From 2014 to 2018
Changes in US Nursing Home Infection Prevention and Control Programs From 2014 to 2018 Open
View article: ADVANCED ILLNESS AMONG ELDERLY NURSING HOME RESIDENTS WITH ALZHEIMER’S DISEASE AND RELATED DEMENTIA
ADVANCED ILLNESS AMONG ELDERLY NURSING HOME RESIDENTS WITH ALZHEIMER’S DISEASE AND RELATED DEMENTIA Open
Alzheimer’s disease and related dementia (AD/ADRD) are leading causes of mortality in the United States. Identifying advanced illness (AI) in NH residents is key for developing therapeutic and palliative care plans for end of life. We refi…
View article: Integration of Palliative Care and Infection Management at the End of Life in U.S. Nursing Homes
Integration of Palliative Care and Infection Management at the End of Life in U.S. Nursing Homes Open